Can this startup save the NFL? High-tech helmet aims to dramatically reduce brain trauma
A concussion crisis is impacting American football at all levels. One out of every three retired NFL players is expected to develop long-term cognitive problems; doctors are criticizing the NCAA for how it protects student-athletes from head trauma; and parents — from LeBron James to Brett Favre — are skeptical of allowing their children to play football due to safety concerns. The future of the NFL, the country’s most popular professional sport, hangs in the balance. Enter Vicis, a new University of Washington spinout that has developed an innovative helmet designed to mitigate the forces that are thought to cause concussions on the football field and in other contact sports. The founding team behind Vicis is impressive. Marver has over two decades of business experience in the medical device space; Chief Medical Officer Dr. Samuel Browd is the director for Seattle Children’s Sports Concussion Program; Chief Technology Officer Per Reinhall is the chairman of the UW Mechanical Engineering Department; and Chief Science Officer Jonathan Posner is an associate professor at the UW Mechanical Engineering Department and an expert in fluid dynamics.
About Seattle Children’s
Consistently ranked as one of the best children’s hospitals in the country by U.S. News & World Report, Seattle Children’s serves as the pediatric and adolescent academic medical referral center for the largest landmass of any children’s hospital in the country (Washington, Alaska, Montana and Idaho). For more than 100 years, Seattle Children’s has been delivering superior patient care while advancing new treatments through pediatric research. Seattle Children’s serves as the primary teaching, clinical and research site for the Department of Pediatrics at the University of Washington School of Medicine. The hospital works in partnership with Seattle Children’s Research Institute and Seattle Children’s Hospital Foundation. For more information, visit www.seattlechildrens.org or follow us on Twitter or Facebook.